Nanomedicines and Vaccines
NANO-VAC
Marina
Sabaté Brescó
Colaboradora Clínica
Publicacións nas que colabora con Marina Sabaté Brescó (9)
2024
-
Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria
Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 1, pp. 195-200
2023
-
Medical algorithm: Diagnosis and management of histaminergic angioedema
Allergy: European Journal of Allergy and Clinical Immunology
2022
-
Angioedema severity and impact on quality of life: Chronic histaminergic angioedema versus chronic spontaneous urticaria
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 3039-3043.e3
-
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines
Clinical and Experimental Allergy
-
SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity
Frontiers in Allergy, Vol. 3
-
Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens
Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4
2021
-
A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 6, pp. 2284-2292
-
The multifaceted mas‐related g protein‐coupled receptor member x2 in allergic diseases and beyond
International Journal of Molecular Sciences, Vol. 22, Núm. 9
2019
-
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1